Overview

Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain

Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the safety and tolerability of a diclofenac patch on the skin.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cerimon Pharmaceuticals
Collaborator:
PPD
Treatments:
Diclofenac
Criteria
Inclusion Criteria:

- 18 to 75 years of age

- Has sustained a painful Grade 1 or 2 ankle sprain (Appendix H) no more than 48 hours
prior to study entry

- Presence of pain of at least 5, with a maximum of 9, on an 11-point Numerical Rating
Scale (NRS)

Exclusion Criteria:

- Grade 3 ankle sprain or bilateral sprain (see Appendix H)

- Previous injury to the same ankle within 3 months prior to current injury

- Aspirin or short half-life NSAID use within 12 hours, or longer half-life NSAID use
within 24 hours prior to study entry (Appendix B)

- Opioid use within 24 hours prior to study entry

- Topical treatment, other than ice packs, applied to the painful region since time of
injury

- A history of peptic ulcer disease within 1 year of study entry, any history of
gastrointestinal bleeding or coagulation disorder

- A history of, or evidence for, underlying disease in the injured ankle, such as
osteoarthritis or gout

- Clinically significant, poorly controlled pulmonary, gastrointestinal, hepatic, renal,
endocrine, or cardiovascular disease

- A history of hypersensitivity to diclofenac or diclofenac-containing products

- A history of intolerance to acetaminophen (rescue medication in this trial)

- A history of skin sensitivity to adhesives (e.g. adhesive tape)

- Pregnant or breastfeeding women and women of child-bearing potential not using
effective means of contraception